Ming Luo, Zhihua Qiu, Xiangyue Tang, Li Wu, Shaojun Li, Juehua Zhu, Yongjun Jiang
Molecular neurobiology 2023 AprPontine infarction is the major subtype of brainstem stroke causing severe neurological deficits. The pathophysiology and treatment of pontine infarction was rarely studied. A rat model of acute pontine infarction was established via injection of endothelin-1 in the pons. Single-cell RNA sequencing was applied to detect the cellular response in pontine infarction. Based on this finding, a potential treatment for pontine infarction targeting microglia was verified. Occlusion of penetrating artery caused by endothelin-1 led to pontine infarction. Single-cell RNA sequencing revealed a subtype of activated microglia, SPP1+ microglia, which were different from M1-like or M2-like depolarization. SPP1+ microglia interacted with oligodendrocytes and contributed to the demyelination of nerve tracts. Cyclin B1 regulated the proliferation of SPP1+ microglia. Cucurbitacin E, a cyclin B1 inhibitor, reduced the proliferation of SPP1+ microglia around the injured myelin sheath and alleviated the demyelination. Moreover, cucurbitacin E treatment decreased the ischemic infarction volume and neurological deficits after pontine infarction. SPP1+ microglia contributed to axonal demyelination in the pontine infarction, and inhibition of SPP1+ microglia provided neuroprotection for pontine infarction. © 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Ming Luo, Zhihua Qiu, Xiangyue Tang, Li Wu, Shaojun Li, Juehua Zhu, Yongjun Jiang. Inhibiting Cyclin B1-treated Pontine Infarction by Suppressing Proliferation of SPP1+ Microglia. Molecular neurobiology. 2023 Apr;60(4):1782-1796
PMID: 36572839
View Full Text